Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00516932 · ClinicalTrials.gov registry record
Pharmacogenomics of Antidepressant Response in Children and Adolescents
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 211
- Enrollment target
NCT00516932: Completed study, sponsored by Duke University.
NCT00516932 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 211 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00516932 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 211 participants
- Enrollment target
Study Summary
This study will identify variations in genes that may be involved in the development of suicidal events or certain behaviors in youth who are exposed to antidepressant medications.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 211 participants |
| Start Date | 2007-05 |
| Est. Completion | 2009-10 |
What the finished NCT00516932 record still lists
NCT00516932 is an observational study that tracks outcomes without assigning an intervention. The registered 211 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00516932 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00516932 about?
NCT00516932 is a clinical study titled "Pharmacogenomics of Antidepressant Response in Children and Adolescents". This study will identify variations in genes that may be involved in the development of suicidal events or certain behaviors in youth who are exposed to antidepressant medications.
What is the current status of trial NCT00516932?
This trial is currently completed. The enrollment target is 211 participants. The study started on 2007-05. Estimated completion is 2009-10.
Who is sponsoring clinical trial NCT00516932?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06698796 · 211 participants · Phase 3
A Study to Understand How the Study Medicine Dazukibart Works in People With Idiopathic Inflammatory Myopathies
- NCT04228978 · 212 participants · NA
Promote Weight Loss in Obese Peripheral Artery Disease (PAD) Patients to Prevent Mobility Loss
- NCT04725721 · 212 participants · NA
Testing FIRST in Youth Outpatient Psychotherapy
- NCT06257576 · 212 participants · Phase 3
Function of Tamsulosin in Older Males Undergoing Surgery with Indwelling Catheter
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia